ATC Group: V08AB02 Iohexol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V08AB02 in the ATC hierarchy

Level Code Title
1 V Various
2 V08 Contrast media
3 V08A X-ray contrast media, iodinated
4 V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
5 V08AB02 Iohexol

Active ingredients in V08AB02

Active Ingredient Description
Iohexol

Iohexol is an effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.

Related product monographs

Title Information Source Document Type  
OMNIPAQUE Solution Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Lithuania (LT)

Malta (MT)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.